Showing 121 - 140 results of 306 for search '"kidney transplant"', query time: 0.09s Refine Results
  1. 121
  2. 122

    Tacrolimus toxicity management in a pregnant kidney transplant recipient with newly diagnosed human immunodeficiency virus: A case report by Ahmad Matarneh, Ravi chokshi, Sundus Sardar, Dinia Salmeron, James O’brien, Fareeha Khalil, Naman Trivedi, Nasrollah Ghahramani, Vaqar Shah

    Published 2025-02-01
    “…Managing kidney transplant recipients during pregnancy presents significant challenges, particularly in balancing the interactions and safety concerns of immunosuppressive medications such as mycophenolate mofetil and tacrolimus. …”
    Get full text
    Article
  3. 123
  4. 124
  5. 125

    Attitudes to Medication after Kidney Transplantation and Their Association with Medication Adherence and Graft Survival: A 2-Year Follow-Up Study by Mirjam Tielen, Job van Exel, Mirjam Laging, Denise K. Beck, Roshni Khemai, Teun van Gelder, Michiel G. H. Betjes, Willem Weimar, Emma K. Massey

    Published 2014-01-01
    “…Nonadherence to medication is a common problem after kidney transplantation. The aim of this study was to explore attitudes towards medication, adherence, and the relationship with clinical outcomes. …”
    Get full text
    Article
  6. 126

    COVID-19 Infection Clinical Profile, Management, Outcome, and Antibody Response in Kidney Transplant Recipients: A Single Centre Experience by Sanjiv Jasuja, Gaurav Sagar, Anupam Bahl, Shalini Verma

    Published 2021-01-01
    “…Experience of COVID-19 in kidney transplant recipients (KTRs) with clinical presentation, management, factors influencing mortality, and antibody response is limited. …”
    Get full text
    Article
  7. 127

    The Kidney Transplant Evaluation Process in the Elderly: Reasons for Being Turned down and Opportunities to Improve Cost-Effectiveness in a Single Center by Beatrice P. Concepcion, Rachel C. Forbes, Aihua Bian, Heidi M. Schaefer

    Published 2016-01-01
    “…Background. The kidney transplant evaluation process for older candidates is complex due to the presence of multiple comorbid conditions. …”
    Get full text
    Article
  8. 128

    CCR7 and CD48 as Predicted Targets in Acute Rejection Related to M1 Macrophage after Pediatric Kidney Transplantation by Jie Zhang, Jun Pei, Chengjun Yu, Jin Luo, Yifan Hong, Yi Hua, Guanghui Wei

    Published 2024-01-01
    “…Background. Kidney transplantation (KT) is the best treatment for end-stage renal disease. …”
    Get full text
    Article
  9. 129

    Acute Renal Failure and Volume Overload Syndrome Secondary to a Femorofemoral Arteriovenous Fistula Angioplasty in a Kidney Transplant Recipient by Dominique Bertrand, Geoffroy Desbuissons, Nicolas Pallet, Albane Sartorius, Christophe Legendre, Marie-France Mamzer, Rebecca Sberro Soussan

    Published 2013-01-01
    “…This paper illustrates the potential deleterious consequences of high-output AVF after kidney transplantation and raises considerations regarding the impact of the fistula on cardiac status and kidney function after kidney transplantation and, consequently, the management AVF after transplantation.…”
    Get full text
    Article
  10. 130

    Tacrolimus Concentration Is Effectively Predicted Using Combined Clinical and Genetic Factors in the Perioperative Period of Kidney Transplantation and Associated with Acute Rejection by Fang Cheng, Qiang Li, Zheng Cui, Zhendi Wang, Fang Zeng, Yu Zhang

    Published 2022-01-01
    “…Combined analysis of genotype and specific clinical factors is important for the formulation of precise tacrolimus dose regimens in the early stage after kidney transplantation.…”
    Get full text
    Article
  11. 131

    Very Early Severe Posttransplant Recurrent Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis after Kidney Transplantation: Two Case Reports by Reda Laamech, Hamza Naciri-Bennani, Diane Giovannini, Johan Noble, Bénédicte Janbon, Paolo Malvezzi, Thomas Jouve, Lionel Rostaing

    Published 2022-01-01
    “…Successful kidney transplantation (KTx) in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV) has been reported with excellent patient and graft survival rates. …”
    Get full text
    Article
  12. 132

    Artificial intelligence assisted risk prediction in organ transplantation: a UK Live-Donor Kidney Transplant Outcome Prediction tool by Hatem Ali, Arun Shroff, Tibor Fülöp, Miklos Z. Molnar, Adnan Sharif, Bernard Burke, Sunil Shroff, David Briggs, Nithya Krishnan

    Published 2025-12-01
    “…Introduction: Predicting the outcome of a kidney transplant involving a living donor advances donor decision-making donors for clinicians and patients. …”
    Get full text
    Article
  13. 133

    Anemia Control in Kidney Transplant Recipients Using Once-Monthly Continuous Erythropoietin Receptor Activator: A Prospective, Observational Study by Klemens Budde, Thomas Rath, Volker Kliem

    Published 2014-01-01
    “…In a multicenter, prospective, observational study of 279 kidney transplant recipients with anemia, the efficacy and safety of once-monthly continuous erythropoietin receptor activator (C.E.R.A.) were assessed to a maximum of 15 months. …”
    Get full text
    Article
  14. 134
  15. 135
  16. 136
  17. 137
  18. 138

    Circulating CD4+CD28null T Cells May Increase the Risk of an Atherosclerotic Vascular Event Shortly after Kidney Transplantation by Michiel G. H. Betjes, Willem Weimar, Nicolle H. R. Litjens

    Published 2013-01-01
    “…In conclusion, the presence of circulating CD4+CD28null T cells is associated with an increased risk for a cardiovascular event shortly after kidney transplantation.…”
    Get full text
    Article
  19. 139

    Successful Antiviral Treatment with Direct-Acting Antivirals for Hepatitis C Virus Infection during Peritransplant Period in a Kidney Transplant Recipient by Giovanni Varotti, Ferdinando Dodi, Ernesto Paoletti, Andrea Bruno, Iris Fontana

    Published 2021-01-01
    “…Hepatitis C virus (HCV) infection continues to represent a poor prognostic factor in kidney transplant (KTx) patients. New direct-acting antiviral agents (DAA) have dramatically changed the therapy management for HCV, showing promising results in terms of sustained virologic response. …”
    Get full text
    Article
  20. 140